Primary Site >> Liver Cancer

Gene >> TP73

  • 1998
  • 1999
  • 2000
  • 2001
  • 2002
  • 2003
  • 2004
  • 2005
  • 2006
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Two new p73 splice variants, gamma and delta, with different transcriptional activity.
PMID: 9802988
Ref: Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver.
PMID: 10362118
Ref: Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma.
PMID: 10393724
Ref: Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma.
PMID: 10408709
Ref: HBV transcription repression in response to genotoxic stress is p53-dependent and abrogated by pX.
PMID: 10602509
Ref: p73 is up-regulated in a subset of hepatocellular carcinomas.
PMID: 10706549
Ref: Mutation analysis of P73 and TP53 in Merkel cell carcinoma.
PMID: 10732753
Ref: Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma.
PMID: 10928060
Ref: Correlation between p21(waf1) and p16(INK4a) expression in hepatocellular carcinoma.
PMID: 11282486
Ref: Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells.
PMID: 11526499
Ref: Comprehensive allelotyping of human intrahepatic cholangiocarcinoma.
PMID: 11555575
Ref: p73 overexpression and nuclear accumulation in hepatitis C virus-associated hepatocellular carcinoma.
PMID: 11991598
Ref: The prognostic molecular markers in hepatocellular carcinoma.
PMID: 12046056
Ref: Overexpression but lack of mutation and methylation of p73 in hepatocellular carcinoma.
PMID: 12546528
Ref: Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma.
PMID: 12531887
Ref: [Determination of expression of eight p53-related genes in hepatocellular carcinoma with tissue microarrays].
PMID: 12866955
Ref: Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.
PMID: 12937151
Ref: Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis.
PMID: 14672555
Ref: Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.
PMID: 14719122
Ref: Quantitative TP73 transcript analysis in hepatocellular carcinomas.
PMID: 14760085
Ref: Discrete breakpoint mapping and shortest region of overlap of chromosome arm 1q gain and 1p loss in human hepatocellular carcinoma detected by semiquantitative microsatellite analysis.
PMID: 15495198
Ref: TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor.
PMID: 15578720
Ref: TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma.
PMID: 16195739
Ref: Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription.
PMID: 16203738
Ref: [Hypermethylation of Ras association domain family protein 1A, hypermethylated in cancer 1 and p73 genes in hepatocellular carcinoma].
PMID: 16412291
Ref: [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
PMID: 16764763
Ref: Autonomous growth and hepatocarcinogenesis in transgenic mice expressing the p53 family inhibitor DNp73.
PMID: 17984115
Ref: Molecular mechanism of p73-mediated regulation of hepatitis B virus core promoter/enhancer II: implications for hepatocarcinogenesis.
PMID: 18342333
Ref: Amphiregulin induces the alternative splicing of p73 into its oncogenic isoform DeltaEx2p73 in human hepatocellular tumors.
PMID: 19664633
Ref: Plk1 regulates liver tumor cell death by phosphorylation of TAp63.
PMID: 19668228
Ref: Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway.
PMID: 19711344
Ref: CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
PMID: 20112070
Ref: Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways.
PMID: 20174822
Ref: Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma.
PMID: 20233581
Ref: MicroRNA-602 regulating tumor suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular carcinoma.
PMID: 20364114
Ref: DeltaNp73beta is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria.
PMID: 20581467
Ref: Prognostic significance of co-expression of nm23 and p57 protein in hepatocellular carcinoma.
PMID: 20880063
Ref: MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
PMID: 21261729
Ref: p53-paralog DNp73 oncogene is repressed by IFNalpha/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor.
PMID: 21399658
Ref: Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: a role for HBV-induced HCC.
PMID: 22030623
Ref: Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis.
PMID: 22962577
Ref: Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of hepatocellular carcinoma in a Chinese population.
PMID: 23065572
Ref: The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells.
PMID: 24052075
Ref: A systemic approach to cancer treatment: tumor cell reprogramming focused on endocrine-related cancers.
PMID: 24304275
Ref: Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
PMID: 24377595
Ref: Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
PMID: 24884809
Ref: CHOP mediates ASPP2-induced autophagic apoptosis in hepatoma cells by releasing Beclin-1 from Bcl-2 and inducing nuclear translocation of Bcl-2.
PMID: 25032846
Ref: Piper betle leaf extracts induced human hepatocellular carcinoma Hep3B cell death via MAPKs regulating the p73 pathway in vitro and in vivo.
PMID: 25371988
Ref: Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinoma.
PMID: 25685469
Ref: Chronic hepatitis C virus infection triggers spontaneous differential expression of biosignatures associated with T cell exhaustion and apoptosis signaling in peripheral blood mononucleocytes.
PMID: 25577277
Ref: The p53R172H mutant does not enhance hepatocellular carcinoma development and progression.
PMID: 25885474
Ref: Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer.
PMID: 27058414
Ref: Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease.
PMID: 27359056
Ref: Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma.
PMID: 27835605
Ref: Matrineinduced apoptosis in Hep3B cells via the inhibition of MDM2.
PMID: 27959389
Ref: Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation.
PMID: 28350813
Ref: TP53INP1 Downregulation Activates a p73-Dependent DUSP10/ERK Signaling Pathway to Promote Metastasis of Hepatocellular Carcinoma.
PMID: 28674078
Ref: Ccdc3: A New P63 Target Involved in Regulation Of Liver Lipid Metabolism.
PMID: 28827783
Ref: si-TP73-AS1 suppressed proliferation and increased the chemotherapeutic response of GC cells to cisplatin.
PMID: 30127981
Ref: Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
PMID: 30282320
Ref: Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma.
PMID: 30386458